University of Washington

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).

1,048 total trials 156 currently recruiting 720 completed early-phase tilt top decile by trial count

University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.

University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.

Top-decile sponsor footprint

University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,048 total, page 9 of 21

TERMINATED NA

Effect of Music Intervention on Infants' Brainstem Encoding of Speech

NCT04509739
TERMINATED

Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma

NCT03718338
COMPLETED NA

Addiction Treatment Outcome Monitoring Study

NCT04155385
COMPLETED NA

SCI Thrive: Efficacy of a Peer-led Online Self-Management Program

NCT04059718
TERMINATED Phase 2

Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT03776864
COMPLETED Phase 1

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

NCT03991884
COMPLETED

Quality of Life in IPF - Patient and Physician Perceptions

NCT04148157
COMPLETED

Iterative Redesign of a Behavioral Skills Training Program for Use in Educational Settings

NCT04199533
COMPLETED NA

Evaluation of Modified Bite-Block for Invasive Imaging Procedures

NCT04236297
COMPLETED NA

Mindful Body Awareness With Medication Treatment for Opioid Use Disorder

NCT04082637
COMPLETED

Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing

NCT03932799
COMPLETED NA

Virtual Reality Meditation for Fatigue

NCT04804462
COMPLETED NA

Adapting Behavioral Activation to Technology Platform

NCT03783533
COMPLETED NA

Comparison of Prosthetic Feet for People With Syme's Amputation (XF Symes Study)

NCT04086641
TERMINATED NA

Pressure Injury Prevention in AE and PFC

NCT03924622
COMPLETED NA

Online Prenatal Trial in Mindfulness Sleep Management

NCT04016428
COMPLETED NA

DDBT Adapted Problem Solving Treatment for Primary Care

NCT03514394
COMPLETED Phase 4

Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years

NCT04068948
COMPLETED Phase 2

Cardiovascular Effects of Racemic Epinephrine Pellets

NCT04688346
COMPLETED NA

A Cohort Study of Weight Loss and Gliosis

NCT03578887
COMPLETED Phase 4

Best Management of Muscle Relaxation- Objective Monitoring

NCT03958201
COMPLETED Phase 4

A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

NCT03882008
COMPLETED NA

A Multi-Level Approach to Heat-Related Illness Prevention in Agricultural Workers

NCT04234802
COMPLETED NA

Veterans Nature Therapy (Vet Hike)

NCT03997344
COMPLETED Phase 2

Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension

NCT03554291
COMPLETED NA

Peer Intervention Latino Immigrant MSM

NCT03922126
COMPLETED NA

The Efficacy of Hypnotic Cognitive Therapy for Chronic Pain in SCI

NCT03857672
COMPLETED NA

Evaluating Change in Drinking Identity as a Mechanism for Reducing Hazardous Drinking - Study 2

NCT03889873
COMPLETED NA

Facilitating Communication Study

NCT03721952
COMPLETED Phase 2

Aztreonam for Pharyngeal Gonorrhea

NCT03867734
COMPLETED NA

Strategies to Improve Pain and Enjoy Life

NCT03743402
TERMINATED Phase 1

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

NCT03660930
TERMINATED NA

Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia

NCT03806192
COMPLETED NA

Audio-visual Stimulation: Sleep Dose Response

NCT03569865
COMPLETED Phase 2

Poststroke Depression in Hemorrhagic Stroke

NCT03826875
COMPLETED Phase 4

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2

NCT03782259
COMPLETED NA

Self-Management Interventions for Chronic Pain Relief With Cancer Survivors

NCT03867760
COMPLETED NA

Trial of Adherence App for Buprenorphine Treatment (TAAB) Study

NCT03779997
COMPLETED NA

A Community Wellness Program for Adults Living With Long-term Physical Disability

NCT03653390
TERMINATED Phase 2

Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma

NCT03486197
COMPLETED Phase 1

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

NCT03749460
COMPLETED Phase 1

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

NCT03331341
COMPLETED NA

ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults

NCT02891564
COMPLETED NA

Emergency Department Longitudinal Integrated Care

NCT03699085
COMPLETED NA

Innovations in Dementia Empowerment and Action

NCT03550131
TERMINATED NA

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

NCT03641287
TERMINATED NA

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

NCT03606486
COMPLETED Phase 2

Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

NCT03579693
COMPLETED NA

Induced Gingivitis & Intra-oral Imaging

NCT03750955
TERMINATED NA

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

NCT03723863
← Previous Page 9 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 127
Phase 2 193
Phase 3 39
Phase 4 65

Therapeutic Areas

Depression 13
Chronic Pain 9
Dementia 8
Multiple Sclerosis 8
Post Traumatic Stress Disorder 7
Stage IV Breast Cancer 6
Pain 6
Anatomic Stage IV Breast Cancer AJCC v8 6
Anatomic Stage III Breast Cancer AJCC v8 6
Spinal Cord Injuries 6

What is open in the University of Washington pipeline

156 recruiting of 1,048 indexed (15% open); 720 completed (69%).

Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).

Top condition: Depression (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Washington: open-pipeline peers nationwide

Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of WashingtonUniversity of Wisconsin, MadisonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillDompé Farmaceutici S.p.AVanderbilt-Ingram Cancer CenterArizona State UniversityGeorgetown University
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,048 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Washington page

1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.

  • 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.